FDA approves Israeli MS treatment Copaxone brand in US
The approval covers a drug developed in Israel under Teva and marketed as Copaxone in the United States. The treatment, for multiple sclerosis, is backed by patents and is expected to reach about 300,000 American patients. The announcement highlights international collaboration and regulatory clearance enabling sales in Kansas and other states.
MENTIONED IN THIS ARTICLE
Sad Sor
Ers
Kansas
Cis Yines Ltd
Israel
Copaxone
Teva Marion
Anti abortion protest denied at presidential inauguration
The Christian Defense Coalition filed a lawsuit claiming free speech rights were violated by denial of permission to protest along Pennsylvania Avenue during the inaugural parade route for President Clinton. The National Park Service denied the request since the area was already reserved by the Presidential Inaugural Committee.
MENTIONED IN THIS ARTICLE
Christian Defense Coalition
Pennsylvania Avenue
Clinton
Jay Sekulow
American Center For Law and Justice
National Park Service
Earle Kattleman
Post Office appoints first inspector general Karla Corcoran
Karla Wolfe Corcoran was named the first inspector general of the U S Postal Service by the governing board after Congress required an IG office. She previously served as assistant auditor general for field activities at the Air Force Audit Agency.
MENTIONED IN THIS ARTICLE
Karla Wolfe Corcoran
U.S. Postal Service
Post Office
Governiing Board
Congress
Corcoran
Air Force Audit Agency
Mattel Fined For Delayed Barbie Collectibles Delivery
Mattel Inc. must pay a 146,186 penalty after failing to deliver collectible Barbie dolls on time as required by FTC rules. The agency said the company did not provide refunds as promised for mail or telephone sales. The $80 Barrie dolls were marketed for display or collections.
MENTIONED IN THIS ARTICLE
Mattel Inc
Federal Trade Commission
Mattel
FTC
Thalidomide Viewed for Leprosy and HIV-Related Conditions
Celgene Corp seeks FDA approval to use thalidomide for erythema nodosum leprosum, a leprosy inflammation, and to treat wasting in HIV AIDS patients. Andrulis Inc plans an early filing to use thalidomide for mouth and throat sores in HIV AIDS patients. Thalidomide’s U S status remains restricted to compassionate use and trials.
MENTIONED IN THIS ARTICLE
Washington
United States
Celgene
U.S
Onl
Andrulis Inc
Beltsville
Also Mentioned on This Page
ARTS
Pimas Ems
Igi
Rey
Ted Price
Ares SY
N Michaels
Cras Pris
FDA
Thia
The
Associated Press
Wmaithicouréo
Ao Erro
Swith Coufot
Bandon SS
Owukins
ORIG
Sage
Rocky
Agg
Fend Geeks
Isbk
Betes
Sidewinder Tose
Ovze
Imaster
UMS
Wee ST Pre Pre
Rome